Cash Flow JCR Pharmaceuticals Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-6,414.00
7,244.00
5,412.00
19,404.00
8,653.00
3,422.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-328.00
-3,538.00
-3,843.00
-9,173.00
588.00
1,165.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-5,486.00
9,312.00
-5,500.00
9,289.00
10,341.00
4,927.00
Cash Flow from Investing Activities
-9,874.00
-2,690.00
-15,002.00
-3,250.00
-3,290.00
-4,161.00
Cash Flow from Financing Activities
9,736.00
-2,031.00
1,948.00
-2,179.00
8,304.00
2,048.00
Net Cash Inflow / Outflow
-5,560.00
5,477.00
-17,455.00
4,472.00
15,333.00
2,834.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
64.00
886.00
1,099.00
612.00
-22.00
20.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of JCR Pharmaceuticals Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-6414
19919
-26,333.00
-132.20%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-328
-13661
13,333.00
97.60%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-5486
27851
-33,337.00
-119.70%
Cash Flow from Investing Activities
-9874
6480
-16,354.00
-252.38%
Cash Flow from Financing Activities
9736
-32704
42,440.00
129.77%
Net Cash Inflow / Outflow
-5560
1356
-6,916.00
-510.03%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
64
-271
335.00
123.62%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -158.91% vs 269.31% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
-5,486.00
9,312.00
-158.91%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
